Early and Sustained Symptom Control with Mirikizumab in Patients with Ulcerative Colitis in the Phase 3 LUCENT Programme.
- DOI
- 10.1093/ecco-jcc/jjae088
- Published
- 2024 Nov 4
- Container
- Journal of Crohn's & colitis
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/ecco-jcc/jjae088,
title = {Early and Sustained Symptom Control with Mirikizumab in Patients with Ulcerative Colitis in the Phase 3 LUCENT Programme.},
author = {Danese S and Dignass A and Matsuoka K and Ferrante M and Long M and Redondo I and Moses R and Maier S and Hunter Gibble T and Morris N and Milch C and Abreu MT},
year = {2024},
journal = {Journal of Crohn's \& colitis},
doi = {10.1093/ecco-jcc/jjae088},
url = {https://doi.org/10.1093/ecco-jcc/jjae088}
}RIS
TY - JOUR TI - Early and Sustained Symptom Control with Mirikizumab in Patients with Ulcerative Colitis in the Phase 3 LUCENT Programme. AU - Danese S AU - Dignass A AU - Matsuoka K AU - Ferrante M AU - Long M AU - Redondo I AU - Moses R AU - Maier S AU - Hunter Gibble T AU - Morris N AU - Milch C AU - Abreu MT PY - 2024 JO - Journal of Crohn's & colitis DO - 10.1093/ecco-jcc/jjae088 UR - https://doi.org/10.1093/ecco-jcc/jjae088 ER -
APA
S, D., A, D., K, M., M, F., M, L., I, R., R, M., S, M., T, H. G., N, M., C, M., & MT, A. (2024). Early and Sustained Symptom Control with Mirikizumab in Patients with Ulcerative Colitis in the Phase 3 LUCENT Programme.. Journal of Crohn's & colitis. https://doi.org/10.1093/ecco-jcc/jjae088
Source records
- pubmed · retrieved 2026-09-26T21:21:22.513Z